MKULQ — Molekule Cashflow Statement
0.000.00%
- $0.01m
- $30.91m
- $0.23m
Annual cashflow statement for Molekule, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -0.153 | -3.32 | -7.92 | -6.17 |
Depreciation | ||||
Deferred Taxes | ||||
Non-Cash Items | 0 | 0.062 | 1.19 | -6.2 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.057 | 0.191 | -0.819 | 2.07 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | -0.096 | -3.07 | -7.8 | -10.6 |
Capital Expenditures | 0 | -0.455 | -1.75 | -0.157 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | — | — | — | -0.35 |
Acquisition of Business | ||||
Cash from Investing Activities | 0 | -0.455 | -1.75 | -0.507 |
Financing Cash Flow Items | — | — | -3.47 | -1.42 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 0 | 5.86 | 26.8 | 13.6 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | -0.096 | 2.33 | 17.3 | 2.43 |